Acerta Pharma closed a Seed round (amount undisclosed) in Mar 2013. The company is based in Oss, Netherlands. Investors in the round: BOM Capital - Brabantse Ontwikkelings Maatschappij. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
